IXS currently trading at a $20M market cap, yet the product pipeline suggests far greater potential. Here's the setup: Franklin Templeton integration has materialized, dual-jurisdiction licensing is in place, and the platform commands $88M in AUM with 220M in related metrics. The market may be pricing this conservatively—or the skeptics have it right. Either way, the next few months could trigger dramatic repricing if adoption accelerates. The question isn't whether this token has a case, but whether institutional-grade infrastructure justifies a significantly higher valuation.